Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Findlow

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Plos One|February 21, 2012
Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activityJames B Wing, Lynne Smart, Ray Borrow, et al.
Infectious Diseases and Therapy|December 4, 2023
Meningococcal Disease in the Post-COVID-19 Era: A Time to PrepareDavid E Bloom, Paolo Bonanni, Federico Martinón-Torres, et al.
Clinical and Diagnostic Laboratory Immunology|August 9, 2005
Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccineRay Borrow, Ingeborg S Aaberge, George F Santos, et al.
Clinical and Vaccine Immunology : CVI|June 28, 2013
Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamicaJay Lucidarme, Stefanie Gilchrist, Lynne S Newbold, et al.
Diagnostic Microbiology and Infectious Disease|June 15, 2025
Interlaboratory study to assess precision and reproducibility of the meningococcal antigen surface expression (MEASURE) assay to quantify factor H binding protein expression at the surface of meningococcal serogroup B strainsJakob Loschko, Paul Liberator, Jamie Findlow, et al.
Human Vaccines|October 9, 2007
Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesiclesMichelle Finney, Thomas Vaughan, Stephen Taylor, et al.
Clinical and Vaccine Immunology : CVI|April 9, 2010
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccineJay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
The Journal of Infectious Diseases|July 19, 2008
Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup BVictoria Davenport, Eleanor Groves, Rachel E Horton, et al.
The Pediatric Infectious Disease Journal|June 16, 2015
Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool AgeDavid A Ishola, Nick Andrews, Pauline Waight, et al.
Infection and Immunity|August 17, 2002
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protectionMoya Burrage, Andrew Robinson, Ray Borrow, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Plos One|February 21, 2012
Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activityJames B Wing, Lynne Smart, Ray Borrow, et al.
Infectious Diseases and Therapy|December 4, 2023
Meningococcal Disease in the Post-COVID-19 Era: A Time to PrepareDavid E Bloom, Paolo Bonanni, Federico Martinón-Torres, et al.
Clinical and Diagnostic Laboratory Immunology|August 9, 2005
Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccineRay Borrow, Ingeborg S Aaberge, George F Santos, et al.
Clinical and Vaccine Immunology : CVI|June 28, 2013
Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamicaJay Lucidarme, Stefanie Gilchrist, Lynne S Newbold, et al.
Diagnostic Microbiology and Infectious Disease|June 15, 2025
Interlaboratory study to assess precision and reproducibility of the meningococcal antigen surface expression (MEASURE) assay to quantify factor H binding protein expression at the surface of meningococcal serogroup B strainsJakob Loschko, Paul Liberator, Jamie Findlow, et al.
Human Vaccines|October 9, 2007
Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesiclesMichelle Finney, Thomas Vaughan, Stephen Taylor, et al.
Clinical and Vaccine Immunology : CVI|April 9, 2010
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccineJay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
The Journal of Infectious Diseases|July 19, 2008
Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup BVictoria Davenport, Eleanor Groves, Rachel E Horton, et al.
The Pediatric Infectious Disease Journal|June 16, 2015
Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool AgeDavid A Ishola, Nick Andrews, Pauline Waight, et al.
Infection and Immunity|August 17, 2002
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protectionMoya Burrage, Andrew Robinson, Ray Borrow, et al.
Pageof 10